Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entrada Therapeutics (TRDA) Change in Taxes (2023 - 2025)

Entrada Therapeutics (TRDA) has 3 years of Change in Taxes data on record, last reported at -$620000.0 in Q4 2025.

  • For Q4 2025, Change in Taxes rose 60.86% year-over-year to -$620000.0; the TTM value through Dec 2025 reached -$667000.0, up 80.13%, while the annual FY2025 figure was -$667000.0, 80.13% up from the prior year.
  • Change in Taxes reached -$620000.0 in Q4 2025 per TRDA's latest filing, down from $620000.0 in the prior quarter.
  • Across five years, Change in Taxes topped out at $7.4 million in Q2 2023 and bottomed at -$7.4 million in Q3 2023.
  • Average Change in Taxes over 3 years is $0.0, with a median of -$620000.0 recorded in 2025.
  • Peak YoY movement for Change in Taxes: plummeted 139.36% in 2024, then soared 133.33% in 2025.
  • A 3-year view of Change in Taxes shows it stood at $4.0 million in 2023, then tumbled by 139.36% to -$1.6 million in 2024, then surged by 60.86% to -$620000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Taxes were -$620000.0 in Q4 2025, $620000.0 in Q3 2025, and -$802000.0 in Q2 2025.